<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160">
 <label>160.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Akinc</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Querbes</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>De</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Qin</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Frank-Kamenetsky</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Jayaprakash</surname>
    <given-names>KN</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms</article-title>. 
  <source>Mol Ther.</source> (
  <year>2010</year>) 
  <volume>18</volume>:
  <fpage>1357</fpage>â€“
  <lpage>64</lpage>. 
  <pub-id pub-id-type="doi">10.1038/mt.2010.85</pub-id>
  <?supplied-pmid 20461061?>
  <pub-id pub-id-type="pmid">20461061</pub-id>
 </mixed-citation>
</ref>
